Cargando…
The MATE trial: a multicentre, mixed-methodology, pilot, randomised controlled trial in neovascular age-related macular degeneration
BACKGROUND/OBJECTIVES: In healthcare research investigating complex interventions, gaps in understanding of processes can be filled by using qualitative methods alongside a quantitative approach. The aim of this mixed-methods pilot trial was to provide feasibility evidence comparing two treatment re...
Autores principales: | Airody, Archana, Baseler, Heidi A., Seymour, Julie, Allgar, Victoria, Mukherjee, Rajarshi, Downey, Louise, Dhar-Munshi, Sushma, Mahmood, Sajjad, Balaskas, Konstantinos, Empeslidis, Theo, Hanson, Rachel L. W., Dorey, Tracey, Szczerbicki, Tom, Sivaprasad, Sobha, Gale, Richard P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116669/ https://www.ncbi.nlm.nih.gov/pubmed/37081576 http://dx.doi.org/10.1186/s40814-023-01288-0 |
Ejemplares similares
-
Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic review
por: Hanson, Rachel L. W., et al.
Publicado: (2022) -
TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
por: Foss, Alexander, et al.
Publicado: (2020) -
Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial
por: Foss, Alexander JE, et al.
Publicado: (2015) -
Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
por: Sivaprasad, Sobha
Publicado: (2008) -
Cortical Atrophy Predicts Visual Performance in Long-Term Central Retinal Disease; GCL, pRNFL and Cortical Thickness Are Key Biomarkers
por: Hanson, Rachel L. W., et al.
Publicado: (2022)